Zobrazeno 1 - 10
of 328
pro vyhledávání: '"Echtay, A."'
Publikováno v:
Frontiers in Endocrinology, Vol 15 (2024)
BackgroundIn addition to conventional treatment and modifications in physical activity and diet, alternative strategies have been investigated to manage, prevent, or delay diabetes in humans. In this regard, one strategy has relied on the immunomodul
Externí odkaz:
https://doaj.org/article/eff8566ca2bc4e54ac3d3a6339e824f5
Autor:
Talal Ashour, Sami Azar, Akram Echtay, Muhammad Farooqi, Tarek Fiad, Mohamed Hassanein, Ahmed Hassoun, Abdul Jabbar, Amin Jayyousi, Kari Ranta, Hani Sabbour, Fatih Tangi, Ibrahim Turfanda
Publikováno v:
Dubai Diabetes and Endocrinology Journal, Pp 1-11 (2023)
Background: Current guidelines recommend that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) with proven cardiovascular benefit should be considered for first-line therapy in patients with type 2 diabetes (T2D) who have/are at high risk of ath
Externí odkaz:
https://doaj.org/article/716fdb93783548ef97d665013e406f57
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alper Sonmez, Hani Sabbour, Akram Echtay, Abbas Mahdi Rahmah, Amani Matook Alhozali, Fahad Sulman alSabaan, Fares H. Haddad, Hinde Iraqi, Ibrahim Elebrashy, Samir N. Assaad, Zaheer Bayat, Zeynep Osar Siva, Mohamed Hassanein
Publikováno v:
Journal of Diabetes, Vol 14, Iss 5, Pp 315-333 (2022)
Abstract The upsurge of type 2 diabetes mellitus is a major public health concern in the Middle East and North Africa (MENA) and Africa (AFR) region, with cardiorenal complications (CRCs) being the predominant cause of premature morbidity and mortali
Externí odkaz:
https://doaj.org/article/5b13a0b65efb42018d34679902d42f2b
Autor:
Khadija Hafidh, Rachid Malek, Khalid Al-Rubeaan, Adri Kok, Fahri Bayram, Akram Echtay, Viraj Rajadhyaksha, Ahmed Hadaoui
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
BackgroundWe evaluated the prevalence of vascular complications and associated risk factors in individuals with type 2 diabetes mellitus (T2DM) initiating second-line glucose-lowering therapy from the Middle East and Africa (MEA) cohort of the 3-year
Externí odkaz:
https://doaj.org/article/7cba735a76f7445abc964d9be0104d6f
Publikováno v:
Frontiers in Endocrinology; 2024, p1-12, 12p
Autor:
Hassanein, Mohamed, Al Awadi, Fatheya F., El Hadidy, Khaled El Sayed, Ali, Sobia Sabir, Echtay, Akram, Djaballah, Khier, Dessapt-Baradez, Cecile, Khazaal, Faris Abdul Kareem, Abu-Hijleh, Mohamad Omar, Al Shaikh, Abdulrahman, Gharbi, Mohamed El Hassan, Shehadeh, Naim, Bennakhi, Abdullah, Al Arouj, Monira
Publikováno v:
In Diabetes Research and Clinical Practice May 2019 151:275-284
Autor:
Echtay, Karim S., Bienengraeber, Martin, Mayinger, Peter, Heimpel, Simone, Winkler, Edith, Druhmann, Doerthe, Frischmuth, Karina, Kamp, Frits, Huang, Shu-Gui
Publikováno v:
In Archives of Biochemistry and Biophysics 1 November 2018 657:41-55
Autor:
Hassanein, Mohamed, Echtay, Akram Salim, Malek, Rachid, Omar, Mahomed, Shaikh, Shehla Sajid, Ekelund, Magnus, Kaplan, Kadriye, Kamaruddin, Nor Azmi
Publikováno v:
In Diabetes Research and Clinical Practice January 2018 135:218-226
Publikováno v:
Journal of Diabetes Mellitus. 13:77-92
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::208cff4f4ec8e42f985c7ca844d16e82
https://doi.org/10.4236/jdm.2023.132008
https://doi.org/10.4236/jdm.2023.132008